Results
|
3361.
|
|
|
3362.
|
|
|
3363.
|
|
|
3364.
|
|
|
3365.
|
|
|
3366.
|
|
|
3367.
|
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapy. [electronic resource] by
- Catalano, V
- Loupakis, F
- Graziano, F
- Torresi, U
- Bisonni, R
- Mari, D
- Fornaro, L
- Baldelli, A M
- Giordani, P
- Rossi, D
- Alessandroni, P
- Giustini, L
- Silva, R R
- Falcone, A
- D'Emidio, S
- Fedeli, S L
Producer: 20090401
In:
British journal of cancer vol. 100
Availability: No items available.
|
|
3368.
|
|
|
3369.
|
|
|
3370.
|
Phase I/II pharmacokinetic and pharmacogenomic study of UGT1A1 polymorphism in elderly patients with advanced non-small cell lung cancer treated with irinotecan. [electronic resource] by
- Yamamoto, N
- Takahashi, T
- Kunikane, H
- Masuda, N
- Eguchi, K
- Shibuya, M
- Takeda, Y
- Isobe, H
- Ogura, T
- Yokoyama, A
- Watanabe, K
Producer: 20090210
In:
Clinical pharmacology and therapeutics vol. 85
Availability: No items available.
|
|
3371.
|
|
|
3372.
|
|
|
3373.
|
|
|
3374.
|
|
|
3375.
|
|
|
3376.
|
Novel sulfobutyl ether cyclodextrin gradient leads to highly active liposomal irinotecan formulation. [electronic resource] by
- Li, ChunLei
- Cui, JingXia
- Wang, CaiXia
- Li, YanHui
- Zhang, Lan
- Xiu, Xian
- Li, YongFeng
- Wei, Na
- Zhang, Li
- Wang, Ping
Producer: 20111214
In:
The Journal of pharmacy and pharmacology vol. 63
Availability: No items available.
|
|
3377.
|
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). [electronic resource] by
- Thuss-Patience, Peter C
- Kretzschmar, Albrecht
- Bichev, Dmitry
- Deist, Tillman
- Hinke, Axel
- Breithaupt, Kirstin
- Dogan, Yasemin
- Gebauer, Bernhard
- Schumacher, Guido
- Reichardt, Peter
Producer: 20111121
In:
European journal of cancer (Oxford, England : 1990) vol. 47
Availability: No items available.
|
|
3378.
|
|
|
3379.
|
Phase I dose-escalation study of intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours. [electronic resource] by
- Van Cutsem, Eric
- Khayat, David
- Verslype, Chris
- Billemont, Bertrand
- Tejpar, Sabine
- Meric, Jean-Baptiste
- Soussan-Lazard, Karen
- Assadourian, Sylvie
- Cartot-Cotton, Sylvaine
- Rixe, Olivier
Producer: 20130227
In:
European journal of cancer (Oxford, England : 1990) vol. 49
Availability: No items available.
|
|
3380.
|
|